These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [The significance of generic valsartan in the treatment of patients]. Vértes A. Lege Artis Med; 2011 Feb; 21(2):117-21. PubMed ID: 21710709 [Abstract] [Full Text] [Related]
9. Single-pill combination of amlodipine and valsartan in the management of hypertension. Flack JM, Hilkert R. Expert Opin Pharmacother; 2009 Aug; 10(12):1979-94. PubMed ID: 19606937 [Abstract] [Full Text] [Related]
13. The angiotensin type 1 receptor antagonist valsartan attenuates pathological ventricular hypertrophy induced by hyperhomocysteinemia in rats. Kassab S, Garadah T, Abu-Hijleh M, Golbahar J, Senok S, Wazir J, Gumaa K. J Renin Angiotensin Aldosterone Syst; 2006 Dec; 7(4):206-11. PubMed ID: 17318789 [Abstract] [Full Text] [Related]
14. Rationale and design of the GISSI-Atrial Fibrillation Trial: a randomized, prospective, multicentre study on the use of valsartan, an angiotensin II AT1-receptor blocker, in the prevention of atrial fibrillation recurrence. Disertori M, Latini R, Maggioni AP, Delise P, Di Pasquale G, Franzosi MG, Staszewsky L, Tognoni G, GISSI-AF Investigators. J Cardiovasc Med (Hagerstown); 2006 Jan; 7(1):29-38. PubMed ID: 16645357 [Abstract] [Full Text] [Related]
15. The angiotensin II receptor antagonist valsartan inhibits endothelin 1-induced vasoconstriction in the skin microcirculation in humans in vivo: influence of the G-protein beta3 subunit (GNB3) C825T polymorphism. Mitchell A, Rushentsova U, Siffert W, Philipp T, Wenzel RR. Clin Pharmacol Ther; 2006 Mar; 79(3):274-81. PubMed ID: 16513451 [Abstract] [Full Text] [Related]
17. Angiotensin II type 1 receptor blockade improves hyperglycemia-induced endothelial dysfunction and reduces proinflammatory cytokine release from leukocytes. Willemsen JM, Westerink JW, Dallinga-Thie GM, van Zonneveld AJ, Gaillard CA, Rabelink TJ, de Koning EJ. J Cardiovasc Pharmacol; 2007 Jan; 49(1):6-12. PubMed ID: 17261957 [Abstract] [Full Text] [Related]
18. [Valsartan improves symptoms and quality of life in patients with chronic heart failure]. Baumhäkel M, Müller U, Böhm M. MMW Fortschr Med; 2008 Apr 10; 150 Suppl 1():48-53. PubMed ID: 18540333 [Abstract] [Full Text] [Related]
19. Contribution of different Nox homologues to cardiac remodeling in two-kidney two-clip renovascular hypertensive rats: effect of valsartan. Wang P, Tang F, Li R, Zhang H, Chen S, Liu P, Huang H. Pharmacol Res; 2007 May 10; 55(5):408-17. PubMed ID: 17324585 [Abstract] [Full Text] [Related]
20. Effects of the angiotensin II type 1 receptor antagonist valsartan on the expression of superoxide dismutase in hypertensive patients. Yang HY, Kao PF, Chen TH, Tomlinson B, Ko WC, Chan P. J Clin Pharmacol; 2007 Mar 10; 47(3):397-403. PubMed ID: 17322151 [Abstract] [Full Text] [Related] Page: [Next] [New Search]